AzTrials
AzTrials

Incipient CataractNCT02561104

Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification Cataract Surgery

A study testing Laser-assisted cataract surgery. and Traditional manual phacoemulsification in people with Incipient Cataract and Senile Nuclear Sclerosis, run by University of Texas Southwestern Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study design will be a prospective study comparing laser-assisted cataract extraction cases and traditional manual phacoemulsification cases. All cases will be performed by faculty-supervised residents at Parkland Memorial Hospital. Read more about this study

Who is it for?
Ages 21 to 99 years
Conditions the study is for
Incipient Cataract, Senile Nuclear Sclerosis
What is being tested?
Laser-assisted cataract surgery. and Traditional manual phacoemulsification
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
148 participants
Where
1 siteUnited States
Study dates
Dec 2015to 19 Jun 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Referred for cataract surgery at Parkland Memorial Hospital
  • Potential post-operative visual acuity of 20/30 or greater determined by potential acuity meter (PAM) testing or modified super pinhole potential acuity of 20/30 or greater
  • Clear intraocular media other than cataract in study eye(s)
  • Subject eyes will have a dilated pupil diameter of at least 6 mm
  • Subject eyes will lack other pre-existing ocular pathology or condition that may confound treatment effects, including diabetic retinopathy, previous retinal detachment, iris neovascularization, amblyopia, optic nerve atrophy or recurrent severe anterior or posterior segment inflammation of unknown etiology.

Who cannot join

  • Severe corneal diseases or prior corneal surgery
  • Active, significant external ocular or eyelid disease
  • History of lens abnormalities including posterior polar cataract and zonular weakness precluding standard non-complex cataract surgery
  • Retinal or posterior segment disease
  • Advanced glaucoma, white or advanced cataract (precluding adequate examination of the posterior pole)
  • Anatomic conditions that prevent placement of the femtosecond laser docking ring
Show all 13Show fewer
  • Corneal opacity that will interfere with the laser beam (hazy cornea)
  • Presence of blood or materials in the anterior chamber
  • Hypotony, advanced glaucoma, or presence of cornea implant
  • Poor dilating pupil such that the iris is not peripheral to the intended diameter for the capsulotomy
  • Condition which would cause inadequate clearance between the intended capsulotomy depth and the corneal endothelium
  • Any contraindication to cataract or kerato-refractive surgery
  • Contact lens wearers must discontinue the use of contacts for an appropriate period of time to ensure that their corneas are stable before screening measurements are performed. For rigid gas permeable (RGP) lenses, it is at least 2-4 weeks before accurate imaging measurements can be performed. Study doctor will assess patient findings and determine how long RGP lens wear must be discontinued prior to surgery. For soft contact lenses, it is at least 3 days prior to study measurements.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Parkland Memorial Hospital

    Dallas, Texas, 75235

Other trials in United States

About this study

Official title: Outcomes of Resident-Performed Laser-Assisted vs Manual Traditional Phacoemulsification

The study design will be a prospective study comparing laser-assisted cataract extraction cases and traditional manual phacoemulsification cases. All cases will be performed by faculty-supervised residents at Parkland Memorial Hospital. This study aims to examine visual acuity and complication rates in femtosecond laser-assisted cataract surgery compared to traditional manual phacoemulsification cataract surgery for the beginning surgeon. In addition, this study will assess the subjective novice surgeon experience and the patient experience in terms of expectations and results.

Read the detailed description

The study design will be a prospective study comparing laser-assisted cataract extraction cases and traditional manual phacoemulsification cases. All cases will be performed by faculty-supervised residents at Parkland Memorial Hospital. Cataract surgery training is a standard requirement of all ophthalmology residents who are part of this clinical study.

Each resident must be a post graduate year 4 (PGY-4) level resident before being asked to be a part of this clinical study. Typically, each resident will have completed approximately 30 cataract surgeries by their PGY-3 residency year of training. These traditional phacoemulsification require manual capsulorrhexis creation with which residents will have experience prior to study participation. Other critical manual surgical steps of traditional and femtosecond-laser assisted cataract surgery require similar surgical skill sets, thus residents should have surgical skills applicable to both techniques prior to study involvement.

In addition to performing 30 traditional phacoemulsification surgeries, residents also will have assisted with femtosecond laser-assisted cases during their PGY-3 training year training at the Dallas VA medical center and with staff at University of Texas (UT) Southwestern Medical Center during their cornea rotation. The femtosecond-assisted cases completed by each resident in the study at Parkland will be the Alcon Certification cases for each resident. Performing femtosecond-laser assisted cases at this level of training will provide objective insights into this new surgical technique in resident hands. Patients will not be subjected to any additional risk due to participation in this study as femtosecond laser Alcon Certification is already being performed by residents as part of their standard UT Southwestern ophthalmology training.

Patient eyes that meet the inclusion and exclusion criteria below will be randomly assigned to either the laser-assisted or the standard manual phacoemulsification group based. Following surgery, patients will return for post-operative visits at post-op day 1, post-op week 1, post-op month 1, and post-op month 3. Subjects will be followed in the Parkland Surgery Chief clinic. Subjects will not necessarily see the same study surgeon during each post-operative visit period. It should be noted this is the standard procedure as currently practiced in the Parkland ophthalmology clinic.

Verification of subject adherence to the post-operative follow-up visit schedule will be overseen by the PI throughout the course of the project. Weekly communication with sub-investigators will take place in order to review any outstanding concerns including recruitment effort, surgery schedules, and post-operative visit timelines. Arrangements for additional visits will also be reviewed and scheduled if medically necessary depending on individual patients' post-operative clinical course. Patients will be assigned to each group during the period of September 2015 through July 2016 and followed as part of the study for 3 months post-operatively.

Patients will be offered the same kerato-refractive procedures including manual limbal relaxing incisions or LenSx astigmatic keratotomy that would be offered to patients who are not part of this study. Patients will also be evaluated for benefit from advanced technology intraocular lenses (Toric for astigmatism and ReStor multifocal) that patients who are not part of the study would be offered. Offering advanced technology lenses or combined kerato-refractive procedures is not expected to influence the visual acuity study outcomes for patients in this study. Patient's clinical history, past medical history and ophthalmic medical notes (in particular pre-operative evaluation, operative, and post-operative follow up) will be reviewed. De-identified data points will be extracted for this project.

Being tested
Laser-assisted cataract surgery., Traditional manual phacoemulsification
Keywords
cataract, phacoemulsification, laser-assisted surgery, femtosecond laser
Medical subject headings
Cataract

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laser-assisted cataract surgery.Procedure or surgery

  • Traditional manual phacoemulsificationProcedure or surgery

Study groups in NCT02561104
Study groupRoleWhat they receive
LenSxExperimentalLaser-assisted cataract surgery performed using the LenSx femtosecond laser.
Receives: Procedure: Laser-assisted cataract surgery.
PhacoExperimentalTraditional manual phacoemulsification cataract surgery
Receives: Procedure: Traditional manual phacoemulsification

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Complication rates

    Complication and adverse event monitoring will occur at each visit: pre-operative, operative, post-op day 1, post-op day 7-14, post-op day 30-60 and 3 mos post-op

    Measured: Operative visit to last post-op visit at 3 mos

  2. Visual Acuity

    Bilateral best spectacle corrected visual acuity

    Measured: Change between baseline and 3 mos post-op.

Secondary outcomes (5)
  1. Patient benefit perception

    Patient perception of results assessed by questionnaire

    Measured: Post-op day 1

  2. Patient benefit perception

    Patient perception of results assessed by questionnaire

    Measured: Post-op day 30-60

  3. Patient benefit perception

    Patient perception of results assessed by questionnaire

    Measured: 3 mos post-op

  4. Corneal Endothelial Cell Count (ECC)

    Specular micrography performed at baseline and post-op day 30-60 OR 3 month post-op* to measure change in ECC

    *3 month ECC test will be done only if test was unable to be performed on post-op day 30-60 visit

    Measured: Change from baseline to post-op day 30-60

  5. Lens removal time

    Comparison of time required for nuclear and cortex removal using the two techniques

    Measured: Operative visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2015 (estimated)
  2. Study startDec 2015
  3. Primary completion19 Jun 2018
  4. Study completion19 Jun 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
148 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02561104
Sponsor's protocol ID
STU 092014-020
Status last verified
May 2020
First submitted
24 Sep 2015
Last updated
21 May 2020
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Laser-assisted cataract surgery. and Traditional manual phacoemulsification in people with Incipient Cataract and Senile Nuclear Sclerosis, run by University of Texas Southwestern Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Complication rates (time frame: Operative visit to last post-op visit at 3 mos). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in